See the Full Picture.
Published loading...Updated

BetterLife Pharma Provides Scientific Update on Neuroplastogenic Activity of BETR-001

Summary by The Record
VANCOUVER, British Columbia, May 28, 2025 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB : BETRF / FRA: NPAU), an emerging biotech company focused on the development of BETR-001, a non-hallucinogenic neuroplastogen in the…

Bias Distribution

  • 100% of the sources lean Left
100% Left
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

The Record broke the news in Waterloo, Canada on Wednesday, May 28, 2025.
Sources are mostly out of (0)